Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.

被引：0
|
作者：
She, Q.-B.
Chandarlapaty, S.
Ye, Q.
Lobo, J.
Haskell, K. M.
Leander, K. R.
DeFeo-Jones, D.
Huber, H. E.
Rosen, N.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Merck Res Labs, West Point, PA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
  • [11] Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
    Kao, Chien-Chang
    Cheng, Yi-Ching
    Yang, Ming-Hsin
    Cha, Tai-Lung
    Sun, Guang-Huan
    Ho, Chi-Tang
    Lin, Ying-Chao
    Wang, Hao-Kuang
    Wu, Sheng-Tang
    Way, Tzong-Der
    ENVIRONMENTAL TOXICOLOGY, 2021, 36 (11) : 2186 - 2195
  • [12] Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Hsu, Shih-Chung
    Ou, Chien-Chih
    Li, Jhy-Wei
    Tseng, Hsiu-Hsueh
    Chuang, Tzu-Chao
    Liu, Jah-Yao
    Chen, Shih-Jung
    Su, Muh-Hwan
    Cheng, Yung-Chi
    Chou, Wei-Yuan
    Kao, Ming-Ching
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [13] Functional analysis of the PI3K/Akt signaling pathway in disseminated tumor cells
    Grabinski, Nicole
    Grupp, Katharina
    Brandt, Burkhard
    Pantel, Klaus
    Juecker, Manfred
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 859 - 859
  • [14] Poncirin Impact on Human HER2 Breast Cancer Cells: Inhibiting Proliferation, Metastasis, and Tumor Growth in Mice Potentially through The PI3K/AKT Pathway
    Yun, Hao
    Li, Jing
    Zhou, Jinwen
    Liu, Yuanwei
    Zhang, Jin
    CELL JOURNAL, 2024, 26 (08) : 496 - 504
  • [15] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Mehta, Gaurav A.
    Parker, Joel S.
    Silva, Grace O.
    Hoadley, Katherine A.
    Perou, Charles M.
    Gatza, Michael L.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (03) : 439 - 450
  • [16] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Gaurav A. Mehta
    Joel S. Parker
    Grace O. Silva
    Katherine A. Hoadley
    Charles M. Perou
    Michael L. Gatza
    Breast Cancer Research and Treatment, 2017, 162 : 439 - 450
  • [17] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Mehta, Gaurav
    Gatza, Michael
    Angus, Steve
    Johnson, Gary
    CANCER RESEARCH, 2018, 78 (13)
  • [18] Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues
    Huang, Weidong
    Lara, Jonathan F.
    Michaelson, Richard
    Sun, Xiu
    Conte, Pierfranco
    Guarneri, Valentina
    Barbieri, Elena
    Ali, Suhail M.
    Leitzel, Kim
    Weidler, Jodi Marie
    Lie, Yolanda
    Haddad, Mojgan
    Paquet, Agnes
    Sperinde, Jeff
    Howitt, John
    Eisenberg, Marcia
    Hurley, Laura
    Petropoulos, Christos J.
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [19] Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells
    Ou, Chien-Chih
    Hsu, Shih-Chung
    Hsieh, Yin-Hui
    Tsou, Wan-Ling
    Chuang, Tzu-Chao
    Liu, Jah-Yao
    Kao, Ming-Ching
    CARCINOGENESIS, 2008, 29 (02) : 299 - 306
  • [20] Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
    Hanker, Ariella B.
    Estrada, Monica Valeria
    Bianchini, Giampaolo
    Moore, Preston D.
    Zhao, Junfei
    Cheng, Feixiong
    Koch, James P.
    Gianni, Luca
    Tyson, Darren R.
    Sanchez, Violeta
    Rexer, Brent N.
    Sanders, Melinda E.
    Zhao, Zhongming
    Stricker, Thomas P.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2017, 77 (12) : 3280 - 3292
12345